CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 132 filers reported holding CTI BIOPHARMA CORP in Q3 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $742,598 | -30.0% | 176,809 | +0.1% | 0.02% | -26.7% |
| Q4 2022 | $1,061,192 | +3.2% | 176,571 | -0.1% | 0.03% | 0.0% |
| Q3 2022 | $1,028,000 | -65.6% | 176,706 | -64.7% | 0.03% | -64.3% |
| Q2 2022 | $2,988,000 | +1.0% | 500,434 | -21.0% | 0.08% | +20.0% |
| Q1 2022 | $2,957,000 | +63.7% | 633,259 | -13.1% | 0.07% | +84.2% |
| Q4 2021 | $1,806,000 | +21.4% | 728,395 | +44.4% | 0.04% | +15.2% |
| Q3 2021 | $1,488,000 | +6663.6% | 504,382 | +4943.8% | 0.03% | +3200.0% |
| Q3 2020 | $22,000 | -98.9% | 10,000 | -97.5% | 0.00% | -97.3% |
| Q2 2018 | $1,965,000 | +25.5% | 394,505 | -1.8% | 0.04% | +23.3% |
| Q1 2018 | $1,566,000 | +137.3% | 401,628 | +63.1% | 0.03% | +150.0% |
| Q4 2017 | $660,000 | – | 246,189 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 8,800,358 | $21,825,000 | 10.02% |
| CAXTON CORP | 2,239,300 | $5,553,000 | 4.54% |
| Altium Capital Management LP | 2,185,000 | $5,419,000 | 1.49% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,483,829 | $3,680,000 | 1.49% |
| Ghost Tree Capital, LLC | 1,200,000 | $2,976,000 | 1.07% |
| Lion Point Capital, LP | 1,223,595 | $3,034,000 | 0.81% |
| BVF INC/IL | 8,929,690 | $22,146,000 | 0.80% |
| NEA Management Company, LLC | 7,140,450 | $17,708,000 | 0.36% |
| Knott David M Jr | 221,079 | $548,000 | 0.19% |
| Lakeside Advisors, INC. | 97,780 | $242,000 | 0.18% |